The equity dimension compounds this. Thousands of people remain incarcerated in jurisdictions where cannabis is now legal ...
Replimune (REPL) stock plunges as the company seeks layoffs following the FDA rejection of its cancer drug RP1 for melanoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results